Pharmacy News

Boehringer Ingelheim Recalls One Lot of Dabigatran

Kate Traynor

BETHESDA, MD 07 Nov 2012—Boehringer Ingelheim Pharmaceuticals Inc. on November 7 announcedExternal Link the recall of one lot of dabigatran etexilate mesylate because of a problem with the drug's packaging.

The recall affects lot 201900, which contains 75-mg capsules of the anticoagulant and bears an expiration date of January 2015. According to Boehringer Ingelheim, a packaging defect may allow moisture to enter the bottles and reduce the effectiveness of the drug.

The company instructed patients to continue using the recalled lot until they can obtain a free replacement from their pharmacy. Boehringer Ingelheim has asked pharmacists to contact patients who received the recalled lot and ask them to return it to the pharmacy.

A "recall packet" for pharmacists and distributors is available from Genco Pharmaceutical Services of Milwaukee. The company can be contacted by phone at 877-319-8963 for information about the recall process.


Contact Us
For questions, comments, or more information on this article, please contact the ASHP News Center at
ASHP Product Listing